|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chain B:
E.C.3.4.21.4
- trypsin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Preferential cleavage: Arg-|-Xaa, Lys-|-Xaa.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
278:37881-37887
(2003)
|
|
PubMed id:
|
|
|
|
|
| |
|
Canonical inhibitor-like interactions explain reactivity of alpha1-proteinase inhibitor Pittsburgh and antithrombin with proteinases.
|
|
A.Dementiev,
M.Simonovic,
K.Volz,
P.G.Gettins.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The serpin antithrombin is a slow thrombin inhibitor that requires heparin to
enhance its reaction rate. In contrast, alpha1-proteinase inhibitor (alpha1PI)
Pittsburgh (P1 Met --> Arg natural variant) inhibits thrombin 17 times faster
than pentasaccharide heparin-activated antithrombin. We present here x-ray
structures of free and S195A trypsin-bound alpha1PI Pittsburgh, which show that
the reactive center loop (RCL) possesses a canonical conformation in the free
serpin that does not change upon binding to S195A trypsin and that contacts the
proteinase only between P2 and P2'. By inference from the structure of heparin
cofactor II bound to S195A thrombin, this RCL conformation is also appropriate
for binding to thrombin. Reaction rates of trypsin and thrombin with alpha1PI
Pittsburgh and antithrombin and their P2 variants show that the low
antithrombin-thrombin reaction rate results from the antithrombin RCL sequence
at P2 and implies that, in solution, the antithrombin RCL must be in a similar
canonical conformation to that found here for alpha1PI Pittsburgh, even in the
nonheparin-activated state. This suggests a general, limited, canonical-like
interaction between serpins and proteinases in their Michaelis complexes.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 4.
FIG. 4. Thrombin and its interactions with inhibitors. a,
superposition, in stereo, of thrombin or S195A thrombin
structures of complexes with PPACK (gold) (Protein Data Bank
code 1HAI [PDB]
), with BPTI (green) (Protein Data Bank code 1BTH [PDB]
), and with heparin cofactor II (red) (Protein Data Bank code
1JMO [PDB]
), showing the identical conformations of all regions except the
surface loops flanking the active site, particularly the 60 loop
and 150 loop. b, stereo representation of the P5-P5' residues of
[1]PI Pittsburgh (cyan)
from the noncovalent complex with S195A trypsin docked into the
thrombin structure found in the noncovalent complex of S195A
thrombin with heparin cofactor II (HCII in magenta).
|
 |
Figure 5.
FIG. 5. Antithrombin RCL conformation and modeled
interaction with thrombin. a, superposition, in stereo, of the
conformations of P5-P5' residues of [1]PI Pittsburgh from
its noncovalent complex with S195A trypsin and of
pentasacharide-activated antithrombin from a structure of the
heterodimer (orange) (Protein Data Bank code 1AZX [PDB]
). These RCLs are aligned such that the P1 residues have the
same horizontal position. The view is rotated 90°
anticlockwise relative to Fig. 1b. b, stereo representation of
the P5-P5' residues of antithrombin from the x-ray structure of
antithrombin heterodimer docked into the thrombin structure
found in the noncovalent complex of S195A thrombin with heparin
cofactor II, showing inappropriate positioning relative to the
catalytic triad and unfavorable interactions with surface loops.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2003,
278,
37881-37887)
copyright 2003.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
L.Meinert Niclasen,
J.G.Olsen,
R.Dagil,
Z.Qing,
O.E.Sørensen,
and
B.B.Kragelund
(2011).
Streptococcal pyogenic exotoxin B (SpeB) boosts the contact system via binding of α-1 antitrypsin.
|
| |
Biochem J,
434,
123-132.
|
 |
|
|
|
|
 |
P.Goettig,
V.Magdolen,
and
H.Brandstetter
(2010).
Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs).
|
| |
Biochimie,
92,
1546-1567.
|
 |
|
|
|
|
 |
C.Drögemüller,
D.Becker,
A.Brunner,
B.Haase,
P.Kircher,
F.Seeliger,
M.Fehr,
U.Baumann,
K.Lindblad-Toh,
and
T.Leeb
(2009).
A missense mutation in the SERPINH1 gene in Dachshunds with osteogenesis imperfecta.
|
| |
PLoS Genet,
5,
e1000579.
|
 |
|
|
|
|
 |
G.Izaguirre,
A.R.Rezaie,
and
S.T.Olson
(2009).
Engineering functional antithrombin exosites in alpha1-proteinase inhibitor that specifically promote the inhibition of factor Xa and factor IXa.
|
| |
J Biol Chem,
284,
1550-1558.
|
 |
|
|
|
|
 |
M.Cugno,
A.Zanichelli,
F.Foieni,
S.Caccia,
and
M.Cicardi
(2009).
C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress.
|
| |
Trends Mol Med,
15,
69-78.
|
 |
|
|
|
|
 |
R.H.Law,
T.Sofian,
W.T.Kan,
A.J.Horvath,
C.R.Hitchen,
C.G.Langendorf,
A.M.Buckle,
J.C.Whisstock,
and
P.B.Coughlin
(2008).
X-ray crystal structure of the fibrinolysis inhibitor alpha2-antiplasmin.
|
| |
Blood,
111,
2049-2052.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.H.Roberts,
and
J.Hejgaard
(2008).
Serpins in plants and green algae.
|
| |
Funct Integr Genomics,
8,
1.
|
 |
|
|
|
|
 |
D.Belorgey,
P.Hägglöf,
S.Karlsson-Li,
and
D.A.Lomas
(2007).
Protein misfolding and the serpinopathies.
|
| |
Prion,
1,
15-20.
|
 |
|
|
|
|
 |
L.Liu,
N.Mushero,
L.Hedstrom,
and
A.Gershenson
(2007).
Short-lived protease serpin complexes: partial disruption of the rat trypsin active site.
|
| |
Protein Sci,
16,
2403-2411.
|
 |
|
|
|
|
 |
D.J.Johnson,
W.Li,
T.E.Adams,
and
J.A.Huntington
(2006).
Antithrombin-S195A factor Xa-heparin structure reveals the allosteric mechanism of antithrombin activation.
|
| |
EMBO J,
25,
2029-2037.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.A.Huntington
(2006).
Shape-shifting serpins--advantages of a mobile mechanism.
|
| |
Trends Biochem Sci,
31,
427-435.
|
 |
|
|
|
|
 |
J.C.Whisstock,
and
S.P.Bottomley
(2006).
Molecular gymnastics: serpin structure, folding and misfolding.
|
| |
Curr Opin Struct Biol,
16,
761-768.
|
 |
|
|
|
|
 |
R.H.Law,
Q.Zhang,
S.McGowan,
A.M.Buckle,
G.A.Silverman,
W.Wong,
C.J.Rosado,
C.G.Langendorf,
R.N.Pike,
P.I.Bird,
and
J.C.Whisstock
(2006).
An overview of the serpin superfamily.
|
| |
Genome Biol,
7,
216.
|
 |
|
|
|
|
 |
S.Skeldal,
J.V.Larsen,
K.E.Pedersen,
H.H.Petersen,
R.Egelund,
A.Christensen,
J.K.Jensen,
J.Gliemann,
and
P.A.Andreasen
(2006).
Binding areas of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex for endocytosis receptors of the low-density lipoprotein receptor family, determined by site-directed mutagenesis.
|
| |
FEBS J,
273,
5143-5159.
|
 |
|
|
|
|
 |
L.D.Tesch,
M.P.Raghavendra,
T.Bedsted-Faarvang,
P.G.Gettins,
and
S.T.Olson
(2005).
Specificity and reactive loop length requirements for crmA inhibition of serine proteases.
|
| |
Protein Sci,
14,
533-542.
|
 |
|
|
|
|
 |
A.Dementiev,
M.Petitou,
J.M.Herbert,
and
P.G.Gettins
(2004).
The ternary complex of antithrombin-anhydrothrombin-heparin reveals the basis of inhibitor specificity.
|
| |
Nat Struct Mol Biol,
11,
863-867.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
W.Li,
D.J.Johnson,
C.T.Esmon,
and
J.A.Huntington
(2004).
Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin.
|
| |
Nat Struct Mol Biol,
11,
857-862.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |